Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bio Green Med Solution
AddedFeb 19, 2024
UpdatedJul 4, 2026
Bio Green Med Solution

Bio Green Med Solution

Public

US-based company specializing in R&D of therapeutics for cancer and serious diseases.

HQ
Berkeley Heights, NJ, US
Founded
1996
Overview
Compare
Fundraising
Employees
Website

Cyclacel Pharmaceuticals, Inc., founded in 1997 by David P. Lane, PhD, is a biotechnology firm based in Berkeley Heights, New Jersey. The company focuses on the research and development of therapeutics for cancer and other serious diseases. Cyclacel's core mission is to harness cell cycle biology to develop innovative cancer medicines. Their product pipeline includes Fadraciclib and CYC140, targeting oncology and hematology indications. The company operates as a public entity traded on Nasdaq under the ticker CYCC.

Cyclacel has achieved significant milestones in its field, including the development of novel drug candidates that leverage cell cycle, transcriptional regulation, epigenetics, and mitosis biology. Under the leadership of CEO Spiro Rombotis, the company has made strides in clinical-stage biopharmaceutical advancements. Notable key people include Paul McBarron, EVP of finance and COO, and Mark Kirschbaum, MD, CMO. Cyclacel reported a net income of $19.1 million in 2021 and continues to impact the biotechnology industry with its pioneering approach to cancer treatment.

Bio Green Med Solution - Quick Facts

When was Bio Green Med Solution founded?

Bio Green Med Solution was founded in 1996.

Where is Bio Green Med Solution's headquarters located?

Bio Green Med Solution's headquarters is located in Berkeley Heights, NJ, US.

When was Bio Green Med Solution's last funding round?

Bio Green Med Solution's most recent funding round was for $1.3M (USD) in December 2023.

How much has Bio Green Med Solution raised to-date?

As of Dec 22, 2023, Bio Green Med Solution has raised a total of $149.5M (USD).

How many employees does Bio Green Med Solution have?

Bio Green Med Solution has 17 employees as of Feb 6, 2024.

Bio Green Med Solution - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • SaaS
Unique IDs
  • secCik: 0001130166
  • ticker: BGMS
  • ticker: BGMSP
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 20 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541720Research and Development in the Social Sciences and Humanities
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 7200Personal Services
  • 7220Photographic Studios, Portrait
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
  • 7220Research and experimental development on social sciences and humanities